MGTX Logo

MeiraGTx Holdings plc (MGTX) 

NASDAQ
Market Cap
$270.73M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
654 of 809
Rank in Industry
355 of 445

Largest Insider Buys in Sector

MGTX Stock Price History Chart

MGTX Stock Performance

About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Insider Activity of MeiraGTx Holdings plc

Over the last 12 months, insiders at MeiraGTx Holdings plc have bought $0 and sold $0 worth of MeiraGTx Holdings plc stock.

On average, over the past 5 years, insiders at MeiraGTx Holdings plc have bought $14.51M and sold $4.69M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 4,347,826 shares for transaction amount of $25M was made by PERCEPTIVE ADVISORS LLC () on 2023‑05‑05.

List of Insider Buy and Sell Transactions, MeiraGTx Holdings plc

2023-05-05PurchasePERCEPTIVE ADVISORS LLC
4.35M
8.3577%
$5.75$25M-1.95%
2022-06-03PurchaseZeldin Robert KCHIEF MEDICAL OFFICER
6
<0.0001%
$7.89$47-6.73%
2022-05-25PurchaseWollin Robert JGENERAL COUNSEL AND SECRETARY
1,000
0.0022%
$7.94$7,940-5.28%
2021-11-17SaleForbes AlexandriaPresident and CEO
30,000
0.0679%
$19.86$595,800-51.18%
2021-11-16SaleForbes AlexandriaPresident and CEO
30,000
0.0678%
$19.97$599,144-51.10%
2021-10-20SaleGiroux RichardCFO & COO
41,400
0.0941%
$21.05$871,371-40.21%
2021-10-19SaleGiroux RichardCFO & COO
2,600
0.0062%
$20.07$52,182-33.88%
2021-10-18SaleForbes AlexandriaPresident and CEO
60,000
0.1271%
$17.36$1.04M-31.36%
2021-10-18SaleNaylor StuartChief Development Officer
24,000
0.0526%
$17.95$430,800-31.36%
2021-07-20SaleNaylor StuartChief Development Officer
18,780
0.0419%
$15.06$282,827-10.03%
2021-07-13SaleNaylor StuartChief Development Officer
5,220
0.0119%
$15.04$78,509-6.75%
2021-06-09SaleForbes AlexandriaPresident and CEO
8,306
0.0187%
$15.04$124,922-6.21%
2021-06-08SaleForbes AlexandriaPresident and CEO
40,360
0.0917%
$15.02$606,207-5.14%
2021-06-08SaleNaylor StuartChief Development Officer
10,080
0.0229%
$15.01$151,301-5.14%
2021-06-07SaleForbes AlexandriaPresident and CEO
11,334
0.026%
$15.03$170,350-4.05%
2021-06-07SaleNaylor StuartChief Development Officer
2,084
0.0048%
$15.02$31,302-4.05%
2021-04-30SaleNaylor StuartChief Development Officer
741
0.0017%
$15.01$11,122-4.34%
2021-04-29SaleNaylor StuartChief Development Officer
1,405
0.0032%
$15.02$21,103-4.47%
2021-04-28SaleNaylor StuartChief Development Officer
3,772
0.0087%
$15.14$57,108-3.43%
2021-02-17SaleForbes AlexandriaPresident and CEO
30,000
0.0669%
$15.57$467,100-6.58%

Insider Historical Profitability

<0.0001%
PERCEPTIVE ADVISORS LLC
11281103
17.7384%
$4.2150<0.0001%
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD10 percent owner
6007746
9.4466%
$4.2110+18.44%
Forbes AlexandriaPresident and CEO
1080781
1.6994%
$4.21020
Giroux RichardCFO & COO
819218
1.2881%
$4.2108
Naylor StuartChief Development Officer
402017
0.6321%
$4.21020
SHENK THOMAS Edirector
157476
0.2476%
$4.2103
Seligman Nicoledirector
5000
0.0079%
$4.2110<0.0001%
Zeldin Robert KCHIEF MEDICAL OFFICER
5000
0.0079%
$4.2110<0.0001%
Wollin Robert JGENERAL COUNSEL AND SECRETARY
1000
0.0016%
$4.2110<0.0001%
MARCUS JOEL Sdirector
0
0%
$4.2103

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Perceptive Advisors$68.72M17.6211.33M0%+$00.05
Johnson & Johnson$40.31M10.336.64M0%+$00.91
Adage Capital Partners Gp L L C$32.12M8.235.29M0%+$00.06
Prosight Management Lp$24.39M6.254.02M-0.82%-$202,816.916.78
683 Capital Management Llc$15.18M3.892.5M0%+$01.7
BlackRock$13.28M3.42.19M-1.41%-$189,863.51<0.0001
ROYCE & ASSOCIATES INC$4.2M1.08692,115+2.98%+$121,400.000.04
State Street$3.46M0.89569,816+1.46%+$49,761.86<0.0001
Dimensional Fund Advisors$2.45M0.63404,096-6.73%-$176,958.66<0.01
Geode Capital Management$2.42M0.62398,094+2.72%+$64,014.21<0.0001
Laurion Capital Management LP$2.23M0.57367,9370%+$00.06
JPMorgan Chase$2.18M0.56358,449-6.76%-$157,789.62<0.0001
Alyeska Investment Group L P$2M0.51330,1820%+$00.01
The Vanguard Group$1.97M0.5323,891+3.67%+$69,622.92<0.0001
Millennium Management LLC$1.76M0.45290,770+115.42%+$945,675.70<0.01
Northern Trust$1.47M0.38242,747-0.74%-$10,938.14<0.0001
Russell Investments Group Ltd$959,052.000.25157,999+1.93%+$18,173.54<0.01
Wellington Management Company$910,264.000.23149,961+2.39%+$21,275.37<0.0001
J. Goldman & Company$819,450.000.21135,000New+$819,450.000.04
Nuveen$810,794.000.21133,5740%+$0<0.0001
Blair William Co Il$802,047.000.21132,1330%+$0<0.01
BNY Mellon$795,528.000.2131,059-12.08%-$109,320.68<0.0001
Privium Fund Management$728,309.000.19119,985New+$728,309.000.21
Los Angeles Capital Management LLC$705,959.000.18116,303New+$705,959.00<0.01
Renaissance Technologies$662,000.000.17109,100+35.7%+$174,146.65<0.01
Morgan Stanley$576,590.000.1594,990-22.46%-$166,985.90<0.0001
Davenport & Company$518,257.000.1385,380+41.46%+$151,901.87<0.01
Bank of America$477,357.000.1278,642+59.85%+$178,737.24<0.0001
Barclays$465,000.000.1276,759-22.19%-$132,626.08<0.0001
Charles Schwab$452,482.000.1274,5440%+$0<0.0001
Change Path Llc$436,000.000.1171,823-6.65%-$31,074.780.02
Fort Sheridan Advisors Llc$432,921.000.1171,321-2.82%-$12,546.760.08
D. E. Shaw & Co.$417,555.000.1168,790+88.03%+$195,490.28<0.01
Citadel Advisors LLC$415,364.000.1168,429-71.04%-$1.02M<0.0001
State of Wisconsin Investment Board$389,694.000.164,200+52.13%+$133,540.00<0.01
Goldman Sachs$330,184.000.0954,396-46.84%-$290,868.58<0.0001
RhumbLine Advisers$290,245.000.0747,818+2.91%+$8,206.35<0.0001
AllianceBernstein$257,611.000.0742,4400%+$0<0.0001
Tocqueville Asset Management$239,765.000.0639,500+16.35%+$33,688.50<0.01
Cubist Systematic Strategies$229,263.000.0637,770+166.16%+$143,123.97<0.01
UBS$229,713.000.0637,844+3.75%+$8,297.69<0.0001
Letko Brosseau$198,489.000.0532,7000%+$0<0.01
Cornercap Investment Counsel Inc$194,009.000.0531,962-0.38%-$734.470.03
Deutsche Bank$188,990.000.0531,135-3.08%-$5,997.18<0.0001
American Century Investments$170,573.000.0428,101New+$170,573.00<0.0001
Jane Street Capital$160,205.000.0426,393-66.05%-$311,681.37<0.0001
Xtx Topco Ltd$134,086.000.0322,090+6.35%+$8,006.310.01
Invesco$114,073.000.0318,793+6.1%+$6,555.57<0.0001
Jump Financial Llc$109,903.000.0318,106-65.8%-$211,429.43<0.01
Kennedy Capital Management Inc$99,894.000.0316,457New+$99,894.00<0.01